SRC and breast carcinoma: Overexpression/activation of Src is sufficient to elicit invadopodia formation and ECM degradation in fibroblasts (which otherwise lack invadopodia) and breast carcinoma cells [28, 29], while treatment with Src inhibitors or expression of kinase-inactive Src mutants, inhibits invadopodia formation and ECM degradation [29, 30].